{"title":"阿尔茨海默病患者胆碱阻滞剂和胆碱模拟剂的药效学特征","authors":"А. М. Ostanin","doi":"10.33920/med-13-2208-05","DOIUrl":null,"url":null,"abstract":"The aim of the study was to investigate the features of anticholinergics and cholinomimetics pharmacodynamics in patients with Alzheimer's disease and to select alternative options in case of incompatibility with lifelong anticholinesterase (AChE) therapy.","PeriodicalId":12259,"journal":{"name":"Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology)","volume":"28 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Features of pharmacodynamics of cholinoblockers and cholinomimetics in Alzheimer’s patients\",\"authors\":\"А. М. Ostanin\",\"doi\":\"10.33920/med-13-2208-05\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The aim of the study was to investigate the features of anticholinergics and cholinomimetics pharmacodynamics in patients with Alzheimer's disease and to select alternative options in case of incompatibility with lifelong anticholinesterase (AChE) therapy.\",\"PeriodicalId\":12259,\"journal\":{\"name\":\"Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology)\",\"volume\":\"28 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-07-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33920/med-13-2208-05\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33920/med-13-2208-05","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Features of pharmacodynamics of cholinoblockers and cholinomimetics in Alzheimer’s patients
The aim of the study was to investigate the features of anticholinergics and cholinomimetics pharmacodynamics in patients with Alzheimer's disease and to select alternative options in case of incompatibility with lifelong anticholinesterase (AChE) therapy.